Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

4.93
-0.1000-1.99%
Post-market: 4.930.00000.00%19:30 EDT
Volume:92.31K
Turnover:455.85K
Market Cap:302.24M
PE:-3.71
High:5.04
Open:5.04
Low:4.82
Close:5.03
52wk High:7.95
52wk Low:2.20
Shares:61.31M
Float Shares:43.63M
Volume Ratio:0.75
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.8389
ROE:-496.21%
ROA:-36.75%
PB:46.14
PE(LYR):-2.68

Loading ...

Press Release: TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call

Dow Jones
·
Apr 29

TriSalus Life Sciences to host first-quarter financial results conference call

Reuters
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TIPRANKS
·
Apr 29

TriSalus publishes investor presentation on pressure-enabled drug delivery for solid tumors

Reuters
·
Apr 15

TriSalus to present new PEDD clinical, preclinical data at SIR 2026 meeting

Reuters
·
Apr 10

TriSalus Life Sciences Appoints Richard Marshall, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Apr 07

TriSalus names Richard Marshall chief medical officer effective June 29

Reuters
·
Apr 07

TriSalus Life Sciences announces annual shareholder meeting notice and proxy statement

Reuters
·
Apr 01

TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland

TIPRANKS
·
Mar 23

TriSalus Life Sciences reports preclinical study of PEDD-delivered nelitolimod in liver tumor models

Reuters
·
Mar 18

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)

TIPRANKS
·
Mar 11

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Mar 10

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Mar 07

TriSalus Life Sciences Publishes Investor Presentation on Pressure-Enabled Drug Delivery for Solid Tumors

Reuters
·
Mar 07

TriSalus Life Sciences price target lowered to $7 from $12 at Canaccord

TIPRANKS
·
Mar 06

TriSalus posts Q4 revenue of USD 13.2 million up 60%

Reuters
·
Mar 06

TriSalus Life Sciences Q4 Income From Operations USD -3.271 Million

THOMSON REUTERS
·
Mar 06

Press Release: TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance

Dow Jones
·
Mar 06

TriSalus Life Sciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
Mar 04

Lake Street Sticks to Its Buy Rating for TriSalus Life Sciences (TLSI)

TIPRANKS
·
Mar 03